Does black cohosh increase the risk of cancer, especially hormone-sensitive cancers such as breast or ovarian cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Black Cohosh Cause Cancer?

Black cohosh does not cause cancer and appears to be safe for use in women with breast cancer, with some evidence suggesting it may actually reduce breast cancer risk and recurrence. 1, 2

Key Evidence on Cancer Risk

The most reassuring data comes from observational studies showing black cohosh is associated with reduced cancer risk rather than increased risk. Specifically, postmenopausal women using black cohosh had a 53% reduction in primary breast cancer risk (adjusted OR = 0.47) and a 25% reduction in recurrence risk (adjusted HR = 0.75) 3. This protective effect is supported by multiple lines of evidence:

Lack of Estrogenic Activity

The primary concern about black cohosh has been its potential estrogenic effects on hormone-sensitive tissues. However, guideline-level evidence clearly demonstrates black cohosh does not exhibit estrogenic activity 2:

  • No estrogen receptor (ER) binding
  • No upregulation of estrogen-dependent genes
  • No stimulation of estrogen-dependent tumor growth in animal models 2
  • No effect on circulating hormone levels or proliferation in estrogen-responsive tissues 3
  • No breast-specific estrogenic effects on cellular morphology or pS2 expression 4

Clinical Safety in Breast Cancer Patients

Guidelines from the American Association of Clinical Endocrinologists (2011) specifically note that concerns about black cohosh's estrogenicity "seem to be allayed" by the absence of ER binding and tumor stimulation 2. Multiple clinical trials in breast cancer survivors showed no adverse effects on cancer outcomes 3, 5.

Important Caveats and Contradictory Evidence

Metastatic Potential - A Critical Warning

One concerning animal study found that black cohosh significantly increased lung metastases in tumor-bearing mice expressing c-erbB2/HER2+ 6. While this did not affect primary tumor development, it raises questions about use in women with existing HER2+ breast cancer. This is the only study showing potential harm, but it addresses the critical outcome of metastatic progression and mortality.

Hepatotoxicity Risk

The more established safety concern is liver toxicity, not cancer 1, 7. Multiple case reports document hepatitis and even liver failure with black cohosh use 1. Guidelines recommend:

  • Use for no more than 6 months 2
  • Avoid in women with liver disease risk 5

Conflicting Laboratory Data

Some in vitro studies show estrogenic effects and increased ER levels in breast cancer cells 8, while others demonstrate anti-estrogenic and antiproliferative effects 9. The clinical data consistently shows no estrogenic effects, suggesting the in vitro findings may not translate to human use 3, 5, 4.

Clinical Recommendations

For women concerned about cancer risk:

  • Black cohosh does not increase cancer risk and may be protective
  • It can be used safely in breast cancer survivors, including those on tamoxifen 10
  • The primary safety concern is hepatotoxicity, not cancer

Practical limitations:

  • Limit use to 6 months due to lack of long-term safety data 2
  • Avoid in women with liver disease
  • Exercise caution in women with HER2+ breast cancer given the single metastasis study 6
  • Note that black cohosh is ineffective for hot flashes compared to placebo in most trials 1

The evidence hierarchy strongly favors safety: Guidelines 1, 2, systematic reviews 3, 5, and clinical trials consistently show no cancer-promoting effects, with observational data suggesting protection. The single concerning animal study 6 is outweighed by human clinical evidence but warrants mention for informed decision-making, particularly regarding metastatic disease.

References

Guideline

american association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Research

Black cohosh and breast cancer: a systematic review.

Integrative cancer therapies, 2014

Research

Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007

Research

Review of black cohosh-induced toxicity and adverse clinical effects.

Journal of environmental science and health. Part C, Toxicology and carcinogenesis, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.